CL2018003268A1 - Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel. - Google Patents
Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel.Info
- Publication number
- CL2018003268A1 CL2018003268A1 CL2018003268A CL2018003268A CL2018003268A1 CL 2018003268 A1 CL2018003268 A1 CL 2018003268A1 CL 2018003268 A CL2018003268 A CL 2018003268A CL 2018003268 A CL2018003268 A CL 2018003268A CL 2018003268 A1 CL2018003268 A1 CL 2018003268A1
- Authority
- CL
- Chile
- Prior art keywords
- skin
- skin disease
- prevent
- same
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UN ÁCIDO CARBOXÍLICO O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DEL MISMO COMO INGREDIENTE ACTIVO PARA USAR EN EL TRATAMIENTO Y/O PREVENCIÓN DE UNA ENFERMEDAD DE LA PIEL. LA INVENCIÓN TAMBIÉN SE REFIERE A UN MÉTODO PARA TRATAR Y/O PREVENIR UNA ENFERMEDAD DE LA PIEL EN UN PACIENTE, EL MÉTODO COMPRENDE ADMINISTRAR UNA CANTIDAD EFECTIVA DE UN ÁCIDO CARBOXÍLICO O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DEL MISMO A UN PACIENTE QUE LO NECESITA. ADEMÁS, LA INVENCIÓN PROPORCIONA USOS COSMÉTICOS DE UNA COMPOSICIÓN QUE COMPRENDE UN ÁCIDO CARBOXÍLICO O UNA SAL DEL MISMO PARA REDUCIR EL ENROJECIMIENTO DE LA PIEL, LESIONES DE LA PIEL, ARRUGAS, IMPUREZAS O IRREGULARIDADES DE LA PIEL. ADEMÁS, LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE COMO INGREDIENTE ACTIVO UN ÁCIDO CARBOXÍLICO O UNA SAL FARMACÉUTICA DEL MISMO PARA USAR PARA MEJORAR LA FUNCIÓN DE BARRERA CUTÁNEA, DONDE LA COMPOSICIÓN FARMACÉUTICA SE ADMINISTRA A UN LACTANTE Y UN MÉTODO PARA TRATAR Y/O PREVENIR UNA ENFERMEDAD DE LA PIEL DE UN PACIENTE, EL MÉTODO COMPRENDE ADMINISTRAR UNA CANTIDAD EFECTIVA DE UN ÁCIDO CARBOXÍLICO O UNA SAL FARMACÉUTICAMENTE ACEPTABLE DEL MISMO A UN PACIENTE QUE LO NECESITA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16169883 | 2016-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018003268A1 true CL2018003268A1 (es) | 2019-02-22 |
Family
ID=56014857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018003268A CL2018003268A1 (es) | 2016-05-17 | 2018-11-16 | Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200360317A1 (es) |
| EP (1) | EP3458042A1 (es) |
| JP (1) | JP2019516796A (es) |
| KR (1) | KR20190008235A (es) |
| CN (1) | CN109152753A (es) |
| AU (1) | AU2017266725A1 (es) |
| BR (1) | BR112018072164A2 (es) |
| CA (1) | CA3020562A1 (es) |
| CL (1) | CL2018003268A1 (es) |
| MX (1) | MX2018013477A (es) |
| RU (1) | RU2018143562A (es) |
| SG (1) | SG11201807911TA (es) |
| WO (1) | WO2017198701A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116194073A (zh) | 2020-07-21 | 2023-05-30 | 化美有限责任公司 | 二酯化妆品制剂及其用途 |
| WO2023170597A1 (en) * | 2022-03-08 | 2023-09-14 | Sila S.P.A. | Topical composition for treating injuries or cutaneous inflammatory states or proctological pathologies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163107A (zh) * | 1996-04-19 | 1997-10-29 | 迟经惠 | 顽癣治疗液 |
| IL136461A0 (en) * | 1997-12-23 | 2001-06-14 | Schering Corp | Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| DE10032964B4 (de) * | 2000-07-06 | 2017-10-12 | Beiersdorf Ag | Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen |
| US20030064081A1 (en) * | 2001-10-01 | 2003-04-03 | Morgan William H. | Topical anti-pruritic composition |
| JPWO2008096730A1 (ja) * | 2007-02-09 | 2010-05-20 | 国立大学法人名古屋大学 | 抗炎症剤及びその用途 |
| CN101380317B (zh) * | 2007-09-07 | 2010-12-08 | 英属开曼群岛商安盛开发药物股份有限公司 | 减缓搔痒症的药学组合物 |
| WO2012131069A1 (en) * | 2011-03-31 | 2012-10-04 | Proponent Biotech Gmbh | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
| ES2748632T3 (es) * | 2012-10-03 | 2020-03-17 | Proponent Biotech Gmbh | Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas |
-
2017
- 2017-05-17 JP JP2019513480A patent/JP2019516796A/ja active Pending
- 2017-05-17 US US16/097,720 patent/US20200360317A1/en not_active Abandoned
- 2017-05-17 MX MX2018013477A patent/MX2018013477A/es unknown
- 2017-05-17 KR KR1020187033154A patent/KR20190008235A/ko unknown
- 2017-05-17 EP EP17723138.8A patent/EP3458042A1/en not_active Withdrawn
- 2017-05-17 RU RU2018143562A patent/RU2018143562A/ru not_active Application Discontinuation
- 2017-05-17 AU AU2017266725A patent/AU2017266725A1/en not_active Abandoned
- 2017-05-17 SG SG11201807911TA patent/SG11201807911TA/en unknown
- 2017-05-17 BR BR112018072164-6A patent/BR112018072164A2/pt not_active Application Discontinuation
- 2017-05-17 CN CN201780029987.1A patent/CN109152753A/zh active Pending
- 2017-05-17 CA CA3020562A patent/CA3020562A1/en not_active Abandoned
- 2017-05-17 WO PCT/EP2017/061826 patent/WO2017198701A1/en active Application Filing
-
2018
- 2018-11-16 CL CL2018003268A patent/CL2018003268A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017266725A1 (en) | 2018-10-04 |
| BR112018072164A2 (pt) | 2019-02-12 |
| EP3458042A1 (en) | 2019-03-27 |
| KR20190008235A (ko) | 2019-01-23 |
| US20200360317A1 (en) | 2020-11-19 |
| JP2019516796A (ja) | 2019-06-20 |
| CN109152753A (zh) | 2019-01-04 |
| RU2018143562A (ru) | 2020-06-17 |
| SG11201807911TA (en) | 2018-10-30 |
| WO2017198701A1 (en) | 2017-11-23 |
| CA3020562A1 (en) | 2017-11-23 |
| MX2018013477A (es) | 2019-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020012595A (es) | Composiciones farmaceuticas topicas. | |
| CL2019003091A1 (es) | Terapia de combinación. | |
| SA521421897B1 (ar) | تركيبة تعتمد على جزء من نباتات طبية أو مستخلصاتها واستخداماتها ومنتجاتها | |
| EA201790568A1 (ru) | Применение двойного агониста рецепторов glp-1/глюкагона пролонгированного действия для лечения неалкогольной жировой болезни печени | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| BR112015008459A2 (pt) | método veterinário de aliviar a aversão ao ruído | |
| CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
| CL2018003268A1 (es) | Ácidos carboxílicos para tratar/prevenir una enfermedad de la piel. | |
| MX2016016400A (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| AR099299A1 (es) | Inhibidor de la proteína de transferencia de éster de colesterilo (cetp) y composiciones farmacéuticas que comprenden dicho inhibidor para uso en el tratamiento o prevención de enfermedades cardiovasculares | |
| EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| AR097216A1 (es) | Composición para el tratamiento contra el envejecimiento de la piel | |
| AR109012A1 (es) | Sistema de administración transdérmica que contiene galantamina o sales de esta | |
| CL2018003270A1 (es) | Una composición farmacéutica que comprende ácido carboxílico para tratar y prevenir congestión nasal. | |
| CL2018003269A1 (es) | Ácidos carboxílicos para aplicación en la primera infancia. | |
| AR101227A1 (es) | Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor | |
| BR112015011391A2 (pt) | uso de pidotimod para tratar a psoríase | |
| CL2016001952A1 (es) | Formulación farmacéutica tópica que comprende 50 a 2.500 ui/ml de sal de heparina, menos de o igual a 30% v/v de agua, 0% a 30% v/v de un alcohol de cadena inferior; y no menos de 45% v/v de un vehículo miscible en agua seleccionado del grupo que comprende propilenglicol, glicerol, glicofurol, polietilenglicol, o sus mezclas, util en tromboflebitis venosa superficial. | |
| RU2016142678A (ru) | Способ лечения и/или предотвращения постугревых рубцов с помощью фиксированной комбинации адапалена или его солей и пероксида бензоила | |
| EA201792206A1 (ru) | Терапевтическое средство для лечения синдрома сухого глаза, содержащее в качестве активного ингредиента нандролон или его сложный эфир или метенолон или его сложный эфир | |
| CY1124107T1 (el) | Συνδυασμος αδαπαλενης και υπεροξειδιου του βενζολιου για τη θεραπευτικη αντιμετωπιση της σοβαρης ακμης | |
| UA106471U (uk) | Засіб для лікування дерматологічних захворювань |